Table of Content

Consumer Health in Lithuania
Euromonitor International
November 2021

List Of Contents And Tables

CONSUMER HEALTH IN LITHUANIA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Economic woes leads to decrease in sales of analgesics in 2021
Panic buying in 2020 leads to a fall in sales in 2021
Dolmen takes lead from Ibuprom, while multinationals remain leading players in analgesics during 2021
PROSPECTS AND OPPORTUNITIES
Healthy sales growth likely during the forecast period, thanks to consumers increasingly self-medicating
Successful vaccination drive set to slow sales of sleep aids during the forecast period
Emergence of modern grocery retailers for distribution of analgesics set to benefit sales
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Fewer cases of colds and flu impedes sales of cough, cold and allergy (hay fever) remedies in 2021
Sales of antihistamines/allergy remedies slow as consumers less allergic in spring thanks to lockdown in 2021
Established brands benefit from consumer loyalty, while local manufacturers lack sufficient resources in 2021
PROSPECTS AND OPPORTUNITIES
Sales expected to recover during the forecast period, while sedentary lifestyles likely to moderate sales growth
If antivirals for COVID-19 is assigned to cough, cold and allergy (hay fever) remedies, significant sales growth will be expected
E-commerce likely to be an emerging distribution channel in cough, cold and allergy (hay fever) remedies
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Digestive remedies sees moderate demand thanks to home cooked meals in 2021
Digestive remedies benefit from increased stress and anxiety in 2021
A Menarini Industrie Farmaceutiche Riunite remains the leading player, while international players continue to dominate the competitive landscape in 2021
PROSPECTS AND OPPORTUNITIES
Contrasting trends set to moderate sales growth during the forecast period
Research leads to new knowledge and products designed to treat ailments which will benefit sales of digestive remedies during the forecast period
Increase in availability of digestive remedies set to boost sales growth during the forecast period
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Demand for dermatologicals slows in 2021 but vaginal antifungals continues to perform well
Demand for hair loss treatments and medicated shampoos boosted in 2021 thanks to additional stress
Multinationals continue to lead leaving little space for local players in 2021
PROSPECTS AND OPPORTUNITIES
Sales of haemorrhoid treatments set to decrease as consumers lose weight during the forecast period
Demand for antiparasitics/lice (head and body) treatments likely to continue falling during the forecast period
Less stress set to lead to slowing sales of hair loss treatments and medicated shampoos during the forecast period
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
WOUND CARE IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Economic uncertainty leads to negative sales growth of wound care in 2021
Pandemic leads to decline in demand for wound care as consumers continue to stay at home in 2021
Multinationals remain dominant in wound care in 2021
PROSPECTS AND OPPORTUNITIES
After rebound in sales of wound care, sales will slow thanks to increased price competition during the forecast period
First aid kits likely to benefit during the forecast period from consumers buying more cars in 2021
Global price increases likely to lead to value sales recovering before volume sales during the forecast period
CATEGORY DATA
Table 36 Sales of Wound Care by Category: Value 2016-2021
Table 37 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 38 NBO Company Shares of Wound Care: % Value 2017-2021
Table 39 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 40 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 41 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Multivitamins and vitamin B drive sales in 2021
Manufacturers of vitamins target higher income consumers in 2021
Private label continues growing its value share in 2021, thanks to quality and availability
PROSPECTS AND OPPORTUNITIES
Multivitamins likely to continue outperforming vitamins during the forecast period, as consumers perceive these to be better value for money
Players likely to focus on retaining customers and attracting new consumers during the forecast period
New vitamin formats expected to be introduced during the forecast period
CATEGORY DATA
Table 42 Sales of Vitamins by Category: Value 2016-2021
Table 43 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 44 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 45 NBO Company Shares of Vitamins: % Value 2017-2021
Table 46 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 47 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 48 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Dietary supplements targeting immune systems perform well in 2021, while impulse products see decrease in demand
Products aimed at strengthening immune systems and overall health see robust sales growth in 2021
Direct selling stays important and the competitive landscape remains fragmented in 2021
PROSPECTS AND OPPORTUNITIES
Sales of dietary supplements set to slow during the forecast period
Veganism likely to boost innovation in dietary supplement products during the forecast period
Eye health to remain important during forecast period as consumers are more online
CATEGORY DATA
Table 49 Sales of Dietary Supplements by Category: Value 2016-2021
Table 50 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 51 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 52 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 53 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 54 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 55 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Herbal/traditional products benefit from consumers self-medicating in 2021
COVID-19 impacts sales of herbal/traditional products positively in 2021
Valentis remains the leading player, but German brands lead herbal/traditional products in 2021
PROSPECTS AND OPPORTUNITIES
Herbal/traditional products likely to see modest sales growth over the forecast period
Herbal/traditional tonics set to benefit from impulse buys again as brick-and-mortar retailers remain open during the forecast period
Herbal/traditional digestive remedies likely to profit from more people moving less often
CATEGORY DATA
Table 56 Sales of Herbal/Traditional Products: Value 2016-2021
Table 57 Sales of Herbal/Traditional Products: % Value Growth 2016-2021
Table 58 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 59 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 60 Forecast Sales of Herbal/Traditional Products: Value 2021-2026
Table 61 Forecast Sales of Herbal/Traditional Products: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sales growth nearly stagnates in 2021, in parallel to the corresponding adult OTC categories
Lockdowns and social distancing leads to fewer cases of cold and flu in 2021, negatively affecting paediatric cough/cold remedies
International companies benefit from economies of scale and large budgets in 2021
PROSPECTS AND OPPORTUNITIES
Economic rebound from pandemic likely to assist in sales growth during the forecast period
Parents likely to continue strengthening their children’s immune systems during the forecast period
Price increases will benefit sales but not volume growth during the forecast period
CATEGORY DATA
Table 62 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 63 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 64 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 65 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 66 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Obesity and influencers drive sales of weight management and wellbeing in 2021
Obesity a public health problem in 2021 and government should take action
Herbalife remains the leading player in 2021, while local players focus on slimming teas
PROSPECTS AND OPPORTUNITIES
Weight management and wellbeing sales to slow during the forecast period
New players with new products likely to enter weight management and wellbeing during the forecast period
Sales of slimming teas likely to see highest growth during the forecast period
CATEGORY DATA
Table 67 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 68 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 69 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 70 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 71 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 72 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN LITHUANIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sales of sports nutrition recover in 2021 thanks to the steep decline in 2020
Unsold stock puts pressure on suppliers to sell remaining products in 2021
Small players account for largest value share in 2021 and local manufacturers remain peripheral in sports nutrition
PROSPECTS AND OPPORTUNITIES
Sales growth of sports nutrition expected to slow in the forecast period as consumers move less often
E-commerce set to become leading distribution channel during the forecast period
Many specialist retailers operating at a loss which may complicate the recovery of sports nutrition during the forecast period
CATEGORY DATA
Table 73 Sales of Sports Nutrition by Category: Value 2016-2021
Table 74 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 75 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 76 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 77 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 78 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026